Method for treating hepatitis c virus infection in treatment failure patients

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050031586A1
SERIAL NO

10490503

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods for treating individuals having an HCV infection, which individuals have failed to respond to therapy with an INF-.alpha. other than consensus interferon (CIFN), or who, following cessation of therapy with an INF-.alpha. other than CIFN, have suffered relapse. The methods generally involve a dosage regimen involving administering a dose of CIFN and a dose of ribavirin for a period of time, where the dosage regimen is effective to achieve a sustained viral response in the individual.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VALEANT PHARMACEUTICALS NORTH AMERICA3300 HYLAND AVENUE COSTA MESA CA 92626

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hsu, Henry H Hillsborough, CA 11 490

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation